Abstract

Problems related to the protection of human rights and freedoms in the healthcare sector are becoming increasingly relevant and significant. This is due to the entry of mankind into the post-industrial era, accompanied by the rapid development of new biomedical technologies. In this regard, a completely justified question arises: are fundamental human rights sufficiently well regulated at the legislative level? Based on this question, the goal of the study was set, which is to study the rights and legitimate interests of citizens in the field of regulation of biomedical technologies, the achievement of which is ensured by setting the following tasks: to reveal the etymology of the term “biotechnology”, giving it a justification not only from a linguistic, but also from a legal point of view; analyze the existing rights and legitimate interests of citizens in the biomedical industry, enshrined in international and domestic regulatory legal acts. To achieve the designated goal and objectives, the formal-legal and logical methods, as well as methods of analysis, synthesis, induction, deduction, were used. The empirical base was formed by legal doctrine, international legal acts, regional acts, domestic legislation. As a result of the study, some domestic and foreign regulations affecting the rights and legitimate interests of citizens in the field of biotechnology development were characterized. It has been established that at the moment the rights and interests at the international and national levels are regulated only fragmentarily, which can lead to a violation of their violation in the healthcare sector. This suggests the need for further research on this topic.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call